Swixx BioPharma is designed to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2014
Funding rounds raised
S
Swixx BioPharma raised undisclosed on January 8, 2022
